Your session is about to expire
← Back to Search
Other
Experimental Formula for Blood Sugar Control
N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 to 240 minutes
Awards & highlights
Study Summary
This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 to 240 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 to 240 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glucose positive area under the curve (AUC)
Secondary outcome measures
Glucose Concentrations
Glucose peak time
Glucose peak value
+4 moreOther outcome measures
Appetite Questionnaire
Glucagon-Like Peptide-1 (GLP-1) Concentrations
Glucagon-Like Peptide-1 (GLP-1) peak time
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental FormulaExperimental Treatment1 Intervention
One 330 ml serving of study product
Group II: Test MealActive Control1 Intervention
40 g Instant oatmeal
Find a Location
Who is running the clinical trial?
Abbott NutritionLead Sponsor
167 Previous Clinical Trials
33,458 Total Patients Enrolled
Sara Thomas, PhD, RDNStudy ChairAbbott Nutrition
2 Previous Clinical Trials
50 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger